BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oyaert M, Boel A, Jacobs J, Van den Bremt S, De Sloovere M, Vanpoucke H, Van Hoovels L. Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease. Clin Chem Lab Med. 2017;55:1564-1573. [PMID: 28222018 DOI: 10.1515/cclm-2016-1012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Castiglione V, Berodes M, Lukas P, Louis E, Cavalier E, Lutteri L. New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics 2022;12:2338. [DOI: 10.3390/diagnostics12102338] [Reference Citation Analysis]
2 Freeman K, Willis BH, Ryan R, Taylor-Phillips S, Clarke A. Comparing outcomes from tailored meta-analysis with outcomes from a setting specific test accuracy study using routine data of faecal calprotectin testing for inflammatory bowel disease. BMC Med Res Methodol 2022;22:192. [PMID: 35820893 DOI: 10.1186/s12874-022-01668-9] [Reference Citation Analysis]
3 Johnson LM, Spannagl M, Wojtalewicz N, Durner J. Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results. Clinical Biochemistry 2022. [DOI: 10.1016/j.clinbiochem.2022.05.002] [Reference Citation Analysis]
4 O'Driscoll S, Piggott C, Benton SC. Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA. Clin Chem Lab Med 2022. [PMID: 35285587 DOI: 10.1515/cclm-2022-0126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lin L, Wyness SP, Jensen R, Bird J, Norgyal T, Jensen G, Johnson LM. Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay. Am J Clin Pathol 2022;157:252-6. [PMID: 34390332 DOI: 10.1093/ajcp/aqab114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kozik A, Pavlova M, Petrov I, Bychkov V, Kim L, Dorozhko E, Cheng C, Rodriguez RD, Sheremet E. A review of surface-enhanced Raman spectroscopy in pathological processes. Anal Chim Acta 2021;1187:338978. [PMID: 34753586 DOI: 10.1016/j.aca.2021.338978] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
7 Nevejan L, Mylemans M, Vander Cruyssen B, Stubbe M, Van Den Bremt S, Hofman L, Infantino M, Manfredi M, Bossuyt X, Van Hoovels L. Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependent. Clin Chem Lab Med 2021. [PMID: 34714981 DOI: 10.1515/cclm-2021-0998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Barbosa JA, Rodrigues LA, Columbus DA, Aguirre JCP, Harding JCS, Cantarelli VS, Costa MO. Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis. Porcine Health Manag 2021;7:48. [PMID: 34429170 DOI: 10.1186/s40813-021-00228-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lee JM, Jang JH, Ryu JH, Yoo J, Lee BI, Kim SJ, Oh EJ. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease. PLoS One 2021;16:e0255974. [PMID: 34383847 DOI: 10.1371/journal.pone.0255974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 D'Amico F, Rubin DT, Kotze PG, Magro F, Siegmund B, Kobayashi T, Olivera PA, Bossuyt P, Pouillon L, Louis E, Domènech E, Ghosh S, Danese S, Peyrin-Biroulet L. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterol J 2021;9:451-60. [PMID: 33961734 DOI: 10.1002/ueg2.12069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
11 Wyness SP, Lin L, Jensen R, Bird J, Norgyal T, Jensen G, Johnson LM. Clinical and Analytical Verification of an Automated Fecal Calprotectin Immunoassay with Extraction Device. J Appl Lab Med 2021;6:931-41. [PMID: 33582792 DOI: 10.1093/jalm/jfaa236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 D'Amico F, Nancey S, Danese S, Peyrin-Biroulet L. A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. J Crohns Colitis 2021;15:152-61. [PMID: 32392336 DOI: 10.1093/ecco-jcc/jjaa093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
13 Roca M, Rodriguez Varela A, Carvajal E, Donat E, Cano F, Armisen A, Vaya MJ, Ekoff H, Hervas D, Rydell N, Ribes-Koninckx C. Fecal calprotectin in healthy children aged 4-16 years. Sci Rep 2020;10:20565. [PMID: 33239728 DOI: 10.1038/s41598-020-77625-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Garnett E, Pagaduan J, Rajapakshe D, Tam E, Kellermayer R, Devaraj S. Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population. Pract Lab Med 2020;22:e00178. [PMID: 33134465 DOI: 10.1016/j.plabm.2020.e00178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Vicente-Steijn R, Jansen JM, Bisheshar R, Haagen IA. Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients. Pract Lab Med 2020;21:e00175. [PMID: 32637525 DOI: 10.1016/j.plabm.2020.e00175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 D'Haens G, Kelly O, Battat R, Silverberg MS, Laharie D, Louis E, Savarino E, Bodini G, Yarur A, Boland BS, Afif W, Li XJ, Hale M, Ho J, Kondragunta V, Huang B, Kuy C, Okada L, Hester KD, Bray KR, Mimms L, Jain A, Singh S, Collins A, Valasek MA, Sandborn WJ, Vermeire S, Dulai PS. Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins. Gastroenterology 2020;158:515-526.e10. [PMID: 31711925 DOI: 10.1053/j.gastro.2019.10.034] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 24.5] [Reference Citation Analysis]
17 Goll R, Heitmann R, Moe ØK, Carlsen K, Florholmen J. Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis. PLoS One 2019;14:e0224895. [PMID: 31790426 DOI: 10.1371/journal.pone.0224895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Zhou W, Qiao H, Yuan W, Yao Z, Liu K, Wang J, Pang Y. Diagnostic utility of fecal calprotectin in patients presenting to the emergency department with suspected acute appendicitis. Am J Emerg Med 2020;38:2303-7. [PMID: 31780188 DOI: 10.1016/j.ajem.2019.10.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Dulai PS, Peyrin-Biroulet L, Danese S, Sands BE, Dignass A, Turner D, Mantzaris G, Schölmerich J, Mary JY, Reinisch W, Sandborn WJ. Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases. Gastroenterology 2019;157:1032-1043.e1. [PMID: 31228441 DOI: 10.1053/j.gastro.2019.06.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
20 Bossuyt PM, Olsen M, Hyde C, Cohen JF. An analysis reveals differences between pragmatic and explanatory diagnostic accuracy studies. J Clin Epidemiol 2020;117:29-35. [PMID: 31561014 DOI: 10.1016/j.jclinepi.2019.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pezzuto F, Scarano A, Marini C, Rossi G, Stocchi R, Di Cerbo A, Di Cerbo A. Assessing the Reliability of Commercially Available Point of Care in Various Clinical Fields. TOPHJ 2019;12:342-68. [DOI: 10.2174/1874944501912010342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Pelkmans LPJ, de Groot MJM, Curvers J. Analytical Performance and Clinicopathologic Correlation of Four Fecal Calprotectin Methods. Am J Clin Pathol 2019;152:392-8. [PMID: 31152542 DOI: 10.1093/ajcp/aqz051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci 2019;56:307-20. [PMID: 31088326 DOI: 10.1080/10408363.2019.1619159] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
24 Juricic G, Brencic T, Tesija-Kuna A, Njegovan M, Honovic L. Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability. Biochem Med (Zagreb) 2019;29:010707. [PMID: 30799976 DOI: 10.11613/BM.2019.010707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Freeman K, Willis BH, Fraser H, Taylor-Phillips S, Clarke A. Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy. BMJ Open. 2019;9:e027428. [PMID: 30852550 DOI: 10.1136/bmjopen-2018-027428] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
26 Ma C, Battat R, Parker CE, Khanna R, Jairath V, Feagan BG. Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease? Expert Review of Gastroenterology & Hepatology 2019;13:319-30. [DOI: 10.1080/17474124.2019.1563481] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
27 Mumolo MG, Bertani L, Ceccarelli L, Laino G, Di Fluri G, Albano E, Tapete G, Costa F. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World J Gastroenterol 2018; 24(33): 3681-3694 [PMID: 30197475 DOI: 10.3748/wjg.v24.i33.3681] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 81] [Article Influence: 24.3] [Reference Citation Analysis]
28 Ayling RM, Kok K. Fecal Calprotectin. Adv Clin Chem 2018;87:161-90. [PMID: 30342711 DOI: 10.1016/bs.acc.2018.07.005] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 17.5] [Reference Citation Analysis]
29 Noebauer B, Ramic L, Konstantin A, Zachbauer C, Einwallner E. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting. Biochem Med (Zagreb) 2017;27:030710. [PMID: 29180918 DOI: 10.11613/BM.2017.030710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Oyaert M, Van den Bremt S, Boel A, Bossuyt X, Van Hoovels L. Do not forget about pre-analytics in faecal calprotectin measurement! Clinica Chimica Acta 2017;473:124-6. [DOI: 10.1016/j.cca.2017.08.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]